Decipher is now part of Veracyte! Learn More
Decipher is now part of Veracyte! Learn More
Leadership
  • Bonnie H. Anderson
    Chairman of the Board and Chief Executive Officer
    Bonnie H. Anderson
    Chairman of the Board and Chief Executive Officer
    Her career spans over 30 years in regulated diagnostics and life science markets. Ms. Anderson cofounded Veracyte in 2008 and served as the company’s President and Chief Executive Officer until 2016, when she was also appointed Chairman of the Board.
    MORE ABOUT Bonnie >
  • Keith Kennedy
    Chief Operating Officer and Chief Financial Officer
    Keith Kennedy
    Chief Operating Officer and Chief Financial Officer
    Mr. Kennedy was named chief operating officer and chief financial officer of Veracyte in July 2019. He has served as the company’s chief financial officer since December 2016 and secretary since November 2017.
    MORE ABOUT Keith >
  • Giulia C. Kennedy, Ph.D.
    Chief Scientific Officer and Chief Medical Officer
    Giulia C. Kennedy, Ph.D.
    Chief Scientific Officer and Chief Medical Officer
    Dr. Kennedy’s scientific leadership, Veracyte continually pushes the boundaries of what is possible in genomic diagnostics, using big data and machine learning to develop tests that answer critical clinical questions.
    MORE ABOUT Giulia >
  • James (Jim) Erlinger
    Executive Vice President, General Counsel and Secretary
    James (Jim) Erlinger
    Executive Vice President, General Counsel and Secretary
    Jim Erlinger is a seasoned attorney and business executive with 35 years of experience in the life sciences, pharmaceutical, drug development and healthcare industries.
    MORE ABOUT James (Jim) >
  • Tina S. Nova, Ph.D.
    General Manager, Thyroid & Urologic Cancers
    Tina S. Nova, Ph.D.
    General Manager, Thyroid & Urologic Cancers
    Tina S. Nova, Ph.D., serves as Veracyte’s general manager, Thyroid & Urology, leading the company’s flagship Afirma franchise in thyroid cancer and market-leading Decipher business in urologic cancers.
    MORE ABOUT Tina S. >
  • Morten Frost
    General Manager, Pulmonology & Breast Cancer
    Morten Frost
    General Manager, Pulmonology & Breast Cancer
    Morten Frost joined Veracyte in January 2021 as General Manager, Pulmonology & Breast Cancer, with global responsibility for strategic business planning and tactical execution, for the company’s lung cancer and interstitial lung disease (ILD) products.
    MORE ABOUT Morten >
  • Alfred (Freddie) Bowie, Jr., Ph.D.
    Vice President, Corporate and Business Development
    Alfred (Freddie) Bowie, Jr., Ph.D.
    Vice President, Corporate and Business Development
    In his role of Vice President of Corporate and Business Development, Dr. Bowie will lead the company’s strategic planning process and is responsible for managing biopharmaceutical collaborations; identifying, evaluating and executing technology and business partnerships; and managing licensing and acquisitions.
    MORE ABOUT Alfred (Freddie) >
  • Tracy Morris
    Vice President, Corporate Communications and Investor Relations
    Tracy Morris
    Vice President, Corporate Communications and Investor Relations
    In this role, she works in tandem with the Chief Executive Officer and executive team to communicate the company’s strategic vision and value proposition to investors and other audiences and ensures that the market-leading company’s brand is articulated in product and other communications.
    MORE ABOUT Tracy >